Allianz Asset Management Gmb H Amarin Corp Plcuk Transaction History

Allianz Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $112,468 - $239,768	-30,898 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $389,068 - $672,322	-81,395 Reduced 72.48%	30,898 $213,000
Q1 2020 May 14, 2020	SELL	$4.0 - $21.53 $277,160 - $1.49 Million	-69,290 Reduced 38.16%	112,293 $449,000
Q4 2019 Feb 13, 2020	SELL	$13.94 - $24.12 $146,579 - $253,621	-10,515 Reduced 5.47%	181,583 $3.89 Million
Q3 2019 Nov 13, 2019	SELL	$13.89 - $23.16 $1.22 Million - $2.03 Million	-87,685 Reduced 31.34%	192,098 $2.91 Million
Q2 2019 Aug 08, 2019	BUY	$16.27 - $20.51 $1.23 Million - $1.55 Million	75,510 Added 36.97%	279,783 $5.43 Million
Q1 2019 May 13, 2019	BUY	$12.61 - $22.33 $170,739 - $302,348	13,540 Added 7.1%	204,273 $4.24 Million
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $3.78 Million - $7 Million	-304,745 Reduced 61.51%	190,733 $2.57 Million
Q3 2018 Nov 13, 2018	BUY	$2.45 - $16.27 $1.21 Million - $8.06 Million	495,478 New	495,478 $8.06 Million

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.